Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer Metastatic to Brain”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT00398437
What this trial is testing

Magnetic Resonance Imaging for the Early Detection of CNS Metastases in Women With Stage IV Breast Cancer

Who this might be right for
Breast CancerMetastatic Cancer
Jules Bordet Institute 96
Not applicableStudy completedNCT03537911
What this trial is testing

Cognitive Support Program for Patients With Brain Metastases

Who this might be right for
Metastases, CNS
University Health Network, Toronto 18
Testing effectiveness (Phase 2)Looking for participantsNCT07100600
What this trial is testing

Trastuzumab Rezetecan Combined With Radiotherapy Versus Trastuzumab Rezetecan in the Treatment of HER2-positive Advanced Breast Cancer With Brain Metastases

Who this might be right for
HER2-positive Advanced Breast CancerBrain MetastasesRadiotherapy
Henan Cancer Hospital 224
Early research (Phase 1)Study completedNCT05021328
What this trial is testing

Toripalimab Combined With Anlotinib and SBRT in Patients With Untreated Brain Metastases of Driven Gene-negative NSCLC

Who this might be right for
NSCLC
Hubei Cancer Hospital 13
Testing effectiveness (Phase 2)Looking for participantsNCT07506109
What this trial is testing

A Phase II Study of Sintilimab Combined With Ipilimumab N01, Cetuximab and Dabrafenib in Patients With Microsatellite-Stable, BRAF V600E-Mutated Metastatic Colorectal Cancer

Who this might be right for
BRAF V600EColorectal CancerSintilimab+4 more
Tianjin Medical University Cancer Institute and Hospital 49
Early research (Phase 1)Active Not RecruitingNCT05538130
What this trial is testing

Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors

Who this might be right for
MelanomaGliomaThyroid Cancer+10 more
Pfizer 148
Not applicableLooking for participantsNCT07272616
What this trial is testing

Detection of Brain Metastases Using a Novel Gadolinium-Weighted MRI Sequence: A Prospective Comparison

Who this might be right for
Brain Neoplasms
Region Stockholm 100
Post-approval studies (Phase 4)UnknownNCT04767828
What this trial is testing

A Single Arm Study of Brain Metastasis in Patients With HER2-positive Breast Cancer

Who this might be right for
TTP
Tianjin Medical University Cancer Institute and Hospital 43
Early research (Phase 1)Active Not RecruitingNCT03423628
What this trial is testing

Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer

Who this might be right for
Recurrent Glioblastoma MultiformePrimary Glioblastoma MultiformeBrain Neoplasms, Malignant+1 more
AstraZeneca 159
Not applicableUnknownNCT03414944
What this trial is testing

Elective Simultaneous Modulated Accelerated Brain Radiation Therapy for NSCLCs With Limited Brain Metastases

Who this might be right for
Brain Metastases
Shandong Cancer Hospital and Institute 30
Not applicableEnded earlyNCT03593330
What this trial is testing

Neurosurgical Transitional Care Programme

Who this might be right for
SurgeryBrain TumorBrain Tumor, Recurrent+19 more
Barts & The London NHS Trust 242
Testing effectiveness (Phase 2)Study completedNCT04338867
What this trial is testing

Nitroglycerin Plus Intracranial Radiotherapy for Brain Metastases in NSCLC Patients

Who this might be right for
Phase II Clinical TrialNinety-six Histologically Confirmed NSCLC Patients With BMRandomized 1:1 to Received TN Plus WBR or Only WBR+1 more
Instituto Nacional de Cancerologia de Mexico 96
Testing effectiveness (Phase 2)UnknownNCT02385136
What this trial is testing

Temozolomide and Concomitant Whole Brain Radiotherapy in NSCLC Patients With Brain Metastases

Who this might be right for
NSCLC
Zhejiang Cancer Hospital 135
Early research (Phase 1)Study completedNCT00527657
What this trial is testing

Temozolomide, Thalidomide, and Lomustine (TTL) in Melanoma Patients

Who this might be right for
Brain NeoplasmsMelanoma
M.D. Anderson Cancer Center 17
Post-approval studies (Phase 4)Study completedNCT00075166
What this trial is testing

Surgery Versus Radiosurgery to Treat Metastatic Brain Tumors

Who this might be right for
Brain NeoplasmsNeoplasm Metastasis
National Institute of Neurological Disorders and Stroke (NINDS) 130
Early research (Phase 1)Looking for participantsNCT06458712
What this trial is testing

Study to Assess Safety, Tolerability and Activity of DSB2455 in Participants With Advanced Malignancies

Who this might be right for
Advanced Cancers (Breast, Ovarian, mCRPC, Pancreatic Ductal Adenocarcinoma (PDAC), Brain Mets) With Specific Mutations (Homologous Recombination Deficiency)
Duke Street Bio Ltd 180
Testing effectiveness (Phase 2)Looking for participantsNCT06161974
What this trial is testing

Study of Olutasidenib and Temozolomide in HGG

Who this might be right for
High Grade GliomaAstrocytomaAstrocytoma, Grade III+16 more
Rigel Pharmaceuticals 60
Testing effectiveness (Phase 2)WithdrawnNCT06676917
What this trial is testing

Datopotamab Deruxtecan (Dato-DXd) for Non-Small Cell Lung Cancer (NSCLC) Patients With Active Brain Metastases

Who this might be right for
Non-small Cell Lung Cancer
MedSIR
Large-scale testing (Phase 3)UnknownNCT03732482
What this trial is testing

Temozolomide Combine With Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost for Non Small Cell Lung Cancer Brain Metastases

Who this might be right for
Non Small Cell Lung Cancer Metastatic
Taizhou Hospital 400
Early research (Phase 1)Study completedNCT00639262
What this trial is testing

Combination of Sorafenib and Radiation for Brain Metastases and Primary Brain Tumors

Who this might be right for
Brain MetastasesPrimary Brain Tumors
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 35
Next Page